China Clamps Down On Chemical Firm Drug Ingredients
This article was originally published in PharmAsia News
Executive Summary
China plans to have in place by the end of this year a new system to control ingredients used in pharmaceuticals. The State FDA says it will focus on ingredients made by chemical firms for the medicine market along with higher production standards. The stricter controls are a response, in part, to complaints of contaminated and other problem goods produced in China for foreign markets. The SFDA and other agencies also plan to keep a closer eye on chemical firms that seek to move into the pharmaceutical market. (Click here for more